Pancreatic cancer tumour initiating cells: the molecular regulation and therapeutic values

J Cell Mol Med. 2012 May;16(5):988-94. doi: 10.1111/j.1582-4934.2011.01478.x.

Abstract

Pancreatic cancer is an aggressive solid tumour characterized by its local invasion, early metastasis and resistance to standard chemotherapy or radiation therapy. Tumour initiating cells (TICs) are not only capable of self-renewal and differentiation, but also play an important role in multi-drug resistance, and thus become a popular topic in cancer research especially in pancreatic cancer. In this review, we summarize the current progress of TICs in tumourigenesis, various newly identified surface markers of pancreatic TICs, and the signalling pathways such as epithelial-mesenchymal transition, sonic hedgehog and Notch that regulate TICs. We also discuss the role which microRNA plays in TICs as well as its application in TIC-targeted therapy along with other approaches.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / metabolism*
  • Animals
  • Anticarcinogenic Agents / therapeutic use
  • Cell Transformation, Neoplastic / drug effects
  • Cell Transformation, Neoplastic / metabolism*
  • Epithelial-Mesenchymal Transition / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Hedgehog Proteins / metabolism
  • Humans
  • Mice
  • MicroRNAs / metabolism
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / metabolism*
  • Receptors, Notch / metabolism
  • Signal Transduction / drug effects

Substances

  • Anticarcinogenic Agents
  • Hedgehog Proteins
  • MicroRNAs
  • Receptors, Notch